UAS Labs Warning Letter
This article was originally published in The Tan Sheet
Executive Summary
Eden Prairie, Minn.-based firm must revise product labeling claims for its DDS-Plus non-dairy powder and capsules, according to a Warning Letter received by the firm following an FDA inspection of its facility in January. The district office singled out Internet claims for the probiotic supplements, including the statement "Bifidus bacteria may play a role in fighting colon cancer and reducing blood cholesterol." Statements touting Joint Formula Glucosamine/Chondroitin with Boswellia 8s MSM as a "natural approach to arthritis pain" also are cited. FDA says the statements render the products unapproved new drugs under the FD&C Act...